SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

The Politicization Of The US Patent System

The Washington Post story, How patent reform’s fraught politics have left USPTO still without a boss (July 30), is a vivid account of how patent reform has divided the US economy, preempting a possible replacement for David Kappos who stepped down 18 months ago. The division is even bigger than portrayed. Universities have lined up en masse to oppose reform, while main street businesses that merely use technology argue for reform. Reminiscent of the partisan divide that has paralyzed US politics, this struggle crosses party lines and extends well beyond the usual inter-industry debates. Framed in terms of combating patent trolls through technical legal fixes, there lurks a broader economic concern – to what extent ordinary retailers, bank, restaurants, local banks, motels, realtors, and travel agents should bear the burden of defending against patents as a cost of doing business.


Latest Comments
  • So this is how we mankind will become extinct? No ... »
  • 'Business methods were generally not patentable in... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    Education/ R&D/ Innovation

    29/08/2014: Biosimilar Medicines Need Strong Regulation, IP Crucial For Innovation, Pharma Says
    27/08/2014: Market Failure, Not IP, The Issue In Ebola Treatment Shortage, WHO Says
    26/08/2014: World Drug Regulatory Authorities Meet In Brazil; Biosimilars In Focus
    25/08/2014: The Politicization Of The US Patent System
    21/08/2014: IP-Watch, DiploFoundation Offer Shared Internship In Geneva
    14/08/2014: IP-Watch Spotlight: WIPO Lex, Database Of Global IP Systems
    11/08/2014: Australia Eyes Copyright Act Amendment To Curb Downloading
    08/08/2014: Global Medical Students Call For Shift To Health Over Trade, R&D
    06/08/2014: Switzerland Continues Work On Changes To Online Copyright Rules
    05/08/2014: Legal Analysis Of CJEU Hearing On Spain’s Case Against Unitary Patent
    05/08/2014: Compulsory Licences Needed For Affordable Hepatitis C Innovative Drug Regimens
    01/08/2014: UK Adopts Private Copying Exception As Some Rightholders Mull Legal Action
    30/07/2014: Poland Eyes IPR Reform To Combat Plagiarism In Scientific Theses
    25/07/2014: Special Report: Update On Implementation Of The EU Patent Package
    24/07/2014: Trade, Innovation, Competition, IP In Two New Discussion Papers
    24/07/2014: New Medicines Patent Pool-Gilead Agreement For New HIV Drug In 112 Countries
    22/07/2014: Microsoft Online Portal Aims At Increased Innovation, IPR Use In Africa
    21/07/2014: EU-Funded Platform Connects SMEs, Researchers On Green Tech
    18/07/2014: Report: Switzerland Again World’s Most Innovative; North-South Innovation Divide Remains
    17/07/2014: EU Commissioner Hails Open Knowledge, Urges Copyright Reform
    15/07/2014: 360 Applicants Bid For Top WIPO Posts; Selection Process Underway
    11/07/2014: More Liability For Internet Intermediaries Could Raise Information Control, Panellists Say
    10/07/2014: Seed Treaty Celebrates Ten Year Anniversary; Focus On Funding, Collaborations
    09/07/2014: 1 Billion Euro First Call For Projects Under EU-Industry Innovation Partnerships
    08/07/2014: WTO Members Open Negotiations On Green Goods Trade Agreement
    07/07/2014: WIPO Copyright Committee In Disarray Again; Development Dimension Questioned
    04/07/2014: Librarians Concerned Digital Content Licences Overriding Exceptions, Limitations
    03/07/2014: EU Works On Strategic Agenda For The Pharma Sector
    03/07/2014: WIPO Copyright Committee: New Broadcasting Treaty Texts Show Narrowing Of Scope
    02/07/2014: WIPO Copyright Committee Opens With Debate Over Broadcasting Treaty
    30/06/2014: WIPO Copyright Committee Plan For Week: Broadcasting, Limitations, Side Events
    30/06/2014: WIPO And Caribbean IP, What’s The Point?
    30/06/2014: EPO President Battistelli’s Term Extended Amid Staff Concerns
    29/06/2014: WIPO Copyright Committee: More Rights Or Limitations/Exceptions?
    20/06/2014: Author Interview: “Innovation Economics: The Race for Global Advantage”
    20/06/2014: US High Court Shuts Door On Many Software Patents
    19/06/2014: KIPO: Developing The Future, Advancing Appropriate Technology Awareness For Sustainable Development
    18/06/2014: Providing Equal Public Access To ICTs To Bridge The Digital Divide
    14/06/2014: WIPO Rediscovers Consensus As Delegates Agree PCT Amendments
    13/06/2014: WIPO Report Indicates Unprecedented Rise In Renewable Energy Tech Innovation
    13/06/2014: New Report Pinpoints Challenges To Open, Sustainable Internet For All
    12/06/2014: TRIPS Council Debates Non-Violations, Innovation, Green Tech Transfer
    11/06/2014: Panels Highlight Community Participation In Development Of Technologies
    10/06/2014: Nations Eye Amendments To PCT, WIPO’s Top Revenue-Earning Treaty
    10/06/2014: Industry Offers Lessons In Deployment Of Technology In Developing Countries
    10/06/2014: Access To Vaccines, Patents Growing Concerns, Panellists Say
    09/06/2014: Sustainable Energy Supply Models Discussed At UNESCO Conference
    09/06/2014: EU Vaccine Industry To Lobby Newly Elected Parliament For Increased Vaccination
    09/06/2014: Biovision: Industry Vision Of Disruptive Innovation Focuses On Production
    06/06/2014: Fight The Fakes Campaign Grows, Now Includes Generics Companies
    Your IP address is 65.123.29.29